about
Alcohol consumption and survival after a breast cancer diagnosis: a literature-based meta-analysis and collaborative analysis of data for 29,239 cases.Breastfeeding in relation to risk of different breast cancer characteristics.A novel model for Ki67 assessment in breast cancer.The association of education with body mass index and waist circumference in the EPIC-PANACEA study.Mitochondrial DNA copy number and future risk of B-cell lymphoma in a nested case-control study in the prospective EPIC cohortKi67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies.Serum levels of vitamin D, parathyroid hormone and calcium in relation to survival following breast cancer.Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort studyOral contraceptives, reproductive history and risk of colorectal cancer in the European Prospective Investigation into Cancer and NutritionGenetic predisposition, parity, age at first childbirth and risk for breast cancer.Prediagnostic immunoglobulin E levels and risk of chronic lymphocytic leukemia, other lymphomas and multiple myeloma-results of the European Prospective Investigation into Cancer and Nutrition.Parity and age at first childbirth in relation to the risk of different breast cancer subgroups.Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifenBreast density and mode of detection in relation to breast cancer specific survival: a cohort study.Anthropometric measures, physical activity, and risk of glioma and meningioma in a large prospective cohort study.Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial.Effects of statin use on volumetric mammographic density: results from the KARMA study.The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study.Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients.Diet and body constitution in relation to subgroups of breast cancer defined by tumour grade, proliferation and key cell cycle regulators.ESTIMATES OF BREAST CANCER GROWTH RATE FROM MAMMOGRAMS AND ITS RELATION TO TUMOUR CHARACTERISTICS.The contribution of risk factors to the higher incidence of invasive and in situ breast cancers in women with higher levels of education in the European prospective investigation into cancer and nutrition.Low-Grade Inflammation, Oxidative Stress and Risk of Invasive Post-Menopausal Breast Cancer - A Nested Case-Control Study from the Malmö Diet and Cancer Cohort.Meat and heme iron intake and risk of squamous cell carcinoma of the upper aero-digestive tract in the European Prospective Investigation into Cancer and Nutrition (EPIC).The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naïve women with N0/N1 primary breast cancer.Statin Use and Breast Cancer Risk in the Nurses' Health Study.Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer.Measuring mammographic density: comparing a fully automated volumetric assessment versus European radiologists' qualitative classificationInfluence of anthropometric factors on tumour biological characteristics of colorectal cancer in men and women: a cohort studyPancreatic cancer risk in relation to sex, lifestyle factors, and pre-diagnostic anthropometry in the Malmö Diet and Cancer Study.Prediagnostic circulating concentrations of plasma insulin-like growth factor-I and risk of lymphoma in the European Prospective Investigation into Cancer and Nutrition.HMG-CoA reductase expression in primary colorectal cancer correlates with favourable clinicopathological characteristics and an improved clinical outcomeGlobal Transcriptional Changes Following Statin Treatment in Breast Cancer.Female white-collar workers remain at higher risk of breast cancer after adjustments for individual risk factors related to reproduction and lifestyleApolipoproteins, lipids and risk of cancer.Stable Peptide of the Endogenous Opioid Enkephalin Precursor and Breast Cancer Risk.An international study to increase concordance in Ki67 scoring.Endometrial cancer risk prediction including serum-based biomarkers: results from the EPIC cohort.The target for statins, HMG-CoA reductase, is expressed in ductal carcinoma-in situ and may predict patient response to radiotherapy.Prediagnostic telomere length and risk of B-cell lymphoma-Results from the EPIC cohort study.
P50
Q30779634-D97568D7-379E-4313-A019-B48219213F85Q33617363-45A84877-24A4-45F1-AF05-5BB7CFE6FE5FQ33801255-AB1ABA43-E609-49A8-B68C-79C51C924F97Q33849485-2B0B5C14-48E7-4068-874C-D96EA0875343Q33948708-68051C1C-4C2B-4BE5-80F7-4D6183CCFD17Q33984087-FCCFFDD1-2AB0-4FFD-897D-A713E8B6EEC5Q34136443-BFAA4E55-A4C1-4E1B-99E8-44AA4AEA8C9DQ34342499-7ED53051-4D3C-48CD-B116-1E6E969C1F1FQ34363520-B882B23B-6F4C-4B63-8C6A-0522841F1424Q34367710-27F37266-AA96-4D0A-AB89-9C4AEE657466Q34586203-16233BD8-D226-4974-AB4D-2685AAFCB366Q34990053-F7F21071-E184-472F-B825-C571DC89B887Q35029556-7BA87E83-5940-4E29-8FD8-BC26B0F246FFQ35134325-186CF14D-8846-4C67-86F4-078FEC7AFDE7Q35202223-E2A1F62F-E580-48AF-8064-0DE37EAF784EQ35583876-4DAC3C77-50A1-4BF4-A583-DBD87CC93C24Q35643266-E656C686-D099-44AE-88F2-268002A6F7AAQ35660389-7E1BA853-A5BC-4148-84F3-F7EA9AF56E64Q35673791-A25923CC-514C-4435-9995-528E997BED6FQ35749411-5DA2ABCA-5231-4133-B31A-C33E500F175DQ35789617-E9B4B93D-4F5E-433B-801D-A67B944553CEQ35874242-8E167A7B-9044-41A8-98E6-6DAE8BF29856Q36071192-56FD8E18-8D3B-4B92-9250-166E867F94D9Q36460192-5438F98A-8B5E-4AD5-B84A-EEDB73856007Q36732425-5E274640-D35F-414D-A025-49E87D94862EQ36828174-A0F0E5C3-9672-400C-A551-7E78D74B3960Q37038650-50383F76-7147-4504-B477-CE9E2C9ADC80Q37402187-37295D6A-54E2-407F-B755-F33A35C173B3Q37418190-6FB98183-099F-4CCC-B2A1-A3B5E269F6D5Q37490985-26C642A5-7DF0-4622-A981-AF803E51D0A3Q37633486-56CCE2C8-EDE6-4F56-B297-608B2A76769FQ37724074-84437C5D-3CC2-4FBD-B318-AD665394038FQ38465041-F9BB973F-5426-474D-BC8A-328A5D1BC5CCQ38812655-43CC4B01-8962-455F-8C74-D8F96D5F7BEBQ38916878-97AB1289-E4AB-48FE-A973-CB8E34A494DEQ38985242-ECBFE012-CDDF-4494-A660-065EF05A1899Q39037175-52531084-E122-42A4-B737-26F228DFF26AQ39116052-AA6301CB-38F6-4353-B0F0-A59A20F189F4Q39201898-B301A265-1607-476B-89A4-8DCC5A11790EQ39202709-1281CA2A-6C09-43B1-9C27-32C36053926D
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Signe Borgquist
@ast
Signe Borgquist
@en
Signe Borgquist
@es
Signe Borgquist
@sl
type
label
Signe Borgquist
@ast
Signe Borgquist
@en
Signe Borgquist
@es
Signe Borgquist
@sl
altLabel
Borgquist S
@en
prefLabel
Signe Borgquist
@ast
Signe Borgquist
@en
Signe Borgquist
@es
Signe Borgquist
@sl
P106
P1153
8920632800
P21
P31
P496
0000-0001-7938-8893
P569
2000-01-01T00:00:00Z